tetano
Editor, Senior Moderator
Cureus
. 2023 Mar 1;15(3):e35633.
doi: 10.7759/cureus.35633. eCollection 2023 Mar.
Neurological Manifestations of Coronavirus Disease 2019 in Hospitalized Patients: A Lebanese Cohort Study
Taghrid El Hajj[SUP] 1 [/SUP], Mahmoud Hassoun[SUP] 2 [/SUP], Ranime Harb[SUP] 3 [/SUP], Oriana Tarabay[SUP] 1 [/SUP], Amine Zarzour[SUP] 1 [/SUP], Maya Zeineddine[SUP] 4 [/SUP]
Affiliations
Abstract
Background: Concerns regarding potential neurologic complications of COVID-19 are being increasingly reported worldwide. Our objective was to investigate the neurologic complications of COVID-19 among a cohort of Lebanese patients with SARS-CoV-2 infection admitted to Rafik Hariri University Hospital (RHUH), the leading COVID-19 testing and treatment center in Lebanon.
Methods: This is a retrospective, single-center, observational study conducted from March to July 2020 at RHUH, Lebanon.
Results: Of 169 hospitalized patients with confirmed SARS-CoV-2 infection (mean {SD} age was 45.75 {19} years and 62.7% were men), 91 patients (53.8%) had severe infection and 78 patients (46.2%) had non-severe infection according to the American Thoracic Society guidelines for community-acquired pneumonia. Overall, 112 patients (66.3%) developed neurologic symptoms: CNS (46.1%), PNS (43.7%), and skeletal muscle injury (2.4%). Compared with patients with non-severe infection, patients with severe infection were significantly older, were male and more likely to have underlying disorders, especially diabetes and cardiac or cerebrovascular disease. Moreover, those patients experienced more typical COVID-19 symptoms at onset of illness such as fever, cough and fatigue. However, there was no significant difference in the frequency of all nervous system manifestations between the severe and the non-severe infection groups (57 {62.6%} vs 55 {70.5%}; p =0.316), except for impaired consciousness, where seven patients had impaired consciousness in the severe group compared to none in the non-severe group (p=0.012).
Conclusion: A wide variety of neurologic symptoms were detected in our Lebanese cohort of hospitalized COVID-19 patients. A comprehensive knowledge of the neurologic manifestations will help healthcare providers to be more attentive to these complications.
Keywords: coronavirus; covid-19; lebanon; middle east; neurological manifestations; sars-cov-2.
. 2023 Mar 1;15(3):e35633.
doi: 10.7759/cureus.35633. eCollection 2023 Mar.
Neurological Manifestations of Coronavirus Disease 2019 in Hospitalized Patients: A Lebanese Cohort Study
Taghrid El Hajj[SUP] 1 [/SUP], Mahmoud Hassoun[SUP] 2 [/SUP], Ranime Harb[SUP] 3 [/SUP], Oriana Tarabay[SUP] 1 [/SUP], Amine Zarzour[SUP] 1 [/SUP], Maya Zeineddine[SUP] 4 [/SUP]
Affiliations
- PMID: 37009339
- PMCID: PMC10064381
- DOI: 10.7759/cureus.35633
Abstract
Background: Concerns regarding potential neurologic complications of COVID-19 are being increasingly reported worldwide. Our objective was to investigate the neurologic complications of COVID-19 among a cohort of Lebanese patients with SARS-CoV-2 infection admitted to Rafik Hariri University Hospital (RHUH), the leading COVID-19 testing and treatment center in Lebanon.
Methods: This is a retrospective, single-center, observational study conducted from March to July 2020 at RHUH, Lebanon.
Results: Of 169 hospitalized patients with confirmed SARS-CoV-2 infection (mean {SD} age was 45.75 {19} years and 62.7% were men), 91 patients (53.8%) had severe infection and 78 patients (46.2%) had non-severe infection according to the American Thoracic Society guidelines for community-acquired pneumonia. Overall, 112 patients (66.3%) developed neurologic symptoms: CNS (46.1%), PNS (43.7%), and skeletal muscle injury (2.4%). Compared with patients with non-severe infection, patients with severe infection were significantly older, were male and more likely to have underlying disorders, especially diabetes and cardiac or cerebrovascular disease. Moreover, those patients experienced more typical COVID-19 symptoms at onset of illness such as fever, cough and fatigue. However, there was no significant difference in the frequency of all nervous system manifestations between the severe and the non-severe infection groups (57 {62.6%} vs 55 {70.5%}; p =0.316), except for impaired consciousness, where seven patients had impaired consciousness in the severe group compared to none in the non-severe group (p=0.012).
Conclusion: A wide variety of neurologic symptoms were detected in our Lebanese cohort of hospitalized COVID-19 patients. A comprehensive knowledge of the neurologic manifestations will help healthcare providers to be more attentive to these complications.
Keywords: coronavirus; covid-19; lebanon; middle east; neurological manifestations; sars-cov-2.